Total Payments
$33,213
2024 Payments
$4,318
Companies
41
Transactions
199
Medicare Patients
4,600
Medicare Billing
$954,025
Payment Breakdown by Category
Other$13,465 (40.5%)
Consulting$11,063 (33.3%)
Food & Beverage$4,428 (13.3%)
Travel$3,699 (11.1%)
Education$546.16 (1.6%)
Gifts$11.94 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $12,385 | 4 | 37.3% |
| Consulting Fee | $11,063 | 5 | 33.3% |
| Food and Beverage | $4,428 | 154 | 13.3% |
| Travel and Lodging | $3,699 | 8 | 11.1% |
| Long term medical supply or device loan | $1,080 | 11 | 3.3% |
| Education | $546.16 | 13 | 1.6% |
| Gift | $11.94 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $14,313 | 25 | $0 (2019) |
| Genentech USA, Inc. | $6,455 | 14 | $0 (2024) |
| HEMA Biologics, LLC | $2,611 | 10 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $2,352 | 4 | $0 (2024) |
| CTI BioPharma Corp. | $1,725 | 1 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $1,605 | 6 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,319 | 26 | $0 (2024) |
| PFIZER INC. | $499.69 | 23 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $225.69 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $222.03 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,318 | 52 | Alnylam Pharmaceuticals Inc. ($2,311) |
| 2023 | $466.81 | 23 | Novartis Pharmaceuticals Corporation ($129.91) |
| 2022 | $1,987 | 14 | CTI BioPharma Corp. ($1,725) |
| 2021 | $2,661 | 15 | HEMA Biologics, LLC ($2,547) |
| 2020 | $3,423 | 13 | Genentech USA, Inc. ($1,735) |
| 2019 | $9,531 | 24 | Genentech USA, Inc. ($4,599) |
| 2018 | $4,946 | 31 | CSL Behring ($4,407) |
| 2017 | $5,880 | 27 | CSL Behring ($5,319) |
All Payment Transactions
199 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Genentech USA, Inc. | Tecentriq (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: BioOncology | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $83.33 | General |
| Category: Oncology | ||||||
| 11/04/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Oncology | ||||||
| 10/31/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Oncology | ||||||
| 10/24/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 10/23/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 10/16/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Rare Disease | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Oncology | ||||||
| 09/27/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 09/25/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Oncology | ||||||
| 09/20/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $30.28 | General |
| Category: Oncology | ||||||
| 09/20/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $1.94 | General |
| Category: Oncology | ||||||
| 09/19/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.01 | General |
| 08/23/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Oncology | ||||||
| 08/05/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: HEMATOLOGY | ||||||
| 07/17/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $8.73 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,226 | 26,221 | $461,252 | $116,721 |
| 2022 | 22 | 1,082 | 21,145 | $428,378 | $115,423 |
| 2021 | 26 | 1,175 | 9,182 | $358,195 | $131,724 |
| 2020 | 30 | 1,117 | 21,521 | $1.5M | $590,157 |
Total Patients
4,600
Total Services
78,069
Medicare Billing
$954,025
Procedure Codes
105
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 181 | 336 | $80,366 | $29,647 | 36.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 30 | 148 | $63,967 | $14,317 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 166 | 190 | $32,419 | $10,822 | 33.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 61 | 71 | $23,620 | $9,101 | 38.5% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 24 | 21,420 | $96,268 | $8,598 | 8.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 48 | 48 | $19,639 | $7,288 | 37.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 65 | 67 | $17,043 | $6,633 | 38.9% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 39 | 248 | $23,652 | $5,396 | 22.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 37 | 101 | $21,204 | $3,976 | 18.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 105 | 390 | $12,630 | $2,848 | 22.6% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 16 | 58 | $12,172 | $2,819 | 23.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 136 | 294 | $4,183 | $2,389 | 57.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $7,029 | $2,272 | 32.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 34 | $4,966 | $2,058 | 41.4% |
| 36591 | Collection of blood sample from implanted device | Office | 2023 | 18 | 91 | $4,512 | $1,803 | 39.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 49 | 173 | $11,287 | $1,757 | 15.6% |
| 99195 | Drawing of blood for a medical problem | Office | 2023 | 11 | 23 | $4,293 | $1,533 | 35.7% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 16 | 56 | $5,512 | $1,188 | 21.5% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 24 | 68 | $4,284 | $795.76 | 18.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 13 | 22 | $1,920 | $540.92 | 28.2% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2023 | 14 | 414 | $6,733 | $342.67 | 5.1% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 11 | 25 | $961.68 | $241.56 | 25.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 37 | 1,357 | $395.13 | $131.04 | 33.2% |
| 85045 | Red blood count, automated test | Office | 2023 | 17 | 18 | $303.24 | $70.38 | 23.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 32 | 60 | $469.92 | $69.55 | 14.8% |
About Dr. Adam Kotowski, MD
Dr. Adam Kotowski, MD is a Specialist healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992813828.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Kotowski, MD has received a total of $33,213 in payments from pharmaceutical and medical device companies, with $4,318 received in 2024. These payments were reported across 199 transactions from 41 companies. The most common payment nature is "Honoraria" ($12,385).
As a Medicare-enrolled provider, Kotowski has provided services to 4,600 Medicare beneficiaries, totaling 78,069 services with total Medicare billing of $954,025. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Hematology & Oncology
- Location Williamsville, NY
- Active Since 08/29/2006
- Last Updated 01/24/2023
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1992813828
Products in Payments
- Afstyla (Biological) $8,507
- HEMLIBRA (Biological) $6,347
- Idelvion (Biological) $5,662
- SevenFact (Biological) $2,611
- GIVLAARI (Drug) $2,321
- Vonjo (Drug) $1,725
- Jivi (Drug) $1,449
- KISQALI (Drug) $1,207
- ELIQUIS (Drug) $265.96
- SOLIRIS (Drug) $199.00
- Multiple Products (Biological) $124.57
- Xofigo (Drug) $107.38
- XTANDI (Drug) $105.89
- REBLOZYL (Biological) $100.86
- Imbruvica (Drug) $98.78
- SARCLISA (Biological) $90.79
- RYBREVANT (Drug) $86.45
- Thrombate III (Biological) $73.59
- KEYTRUDA (Biological) $72.66
- CARVYKTI (Drug) $61.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Williamsville
Dr. Todd Koch, M.d, M.D
Specialist — Payments: $44,690
Specialist $44,690
Dr. Subramanya Shastri, Md, MD
Specialist — Payments: $42,000
Specialist $42,000
Dr. John Fahrbach, M.d, M.D
Specialist — Payments: $29,379
Specialist $29,379
Dr. Edward Legarreta, Md, MD
Specialist — Payments: $4,381
Specialist $4,381
Dr. Paul Wopperer, M.d, M.D
Specialist — Payments: $3,713
Specialist $3,713
Evan Evans, Md, MD
Specialist — Payments: $3,649
Specialist $3,649